DCT
1:15-cv-01000
AstraZeneca LP v. Sigmapharm Laboratories LLC
General
Filed
10/30/15
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (11/04/19)
Patent Owner
Operating Company (W)
PACER
1:15-cv-01000
CourtD. Delaware
| Judge | Period | PO Win Rate | 
|---|---|---|
| 11/04/15 - 11/04/19 | 31% | 
Magistrate
Mary Pat Thynge
Plaintiff
Party
| Name | Ratings | 
|---|---|
| L5 A | |
| L5 A | |
| L5 A | |
| L5 A | 
No Parties
Attorney
No Attorneys
Defendant
Party
| Name | Ratings | 
|---|---|
| L1 D | |
| L5 E | |
| L5 E | |
| L5 E | |
| L5 E | |
| L5 E | |
| L4 E | |
| L4 E | |
| L3 E | |
| L2 D | |
| -- -- -- | |
| -- -- -- | 
No Parties
Attorney
| Name | Ratings | 
|---|---|
| L5 A | |
| L5 A | |
| L5 A | |
| L3 E | |
| L5 A | |
| L3 D | |
| L2 E | |
| -- -- -- | |
| L5 B | |
| L4 B | |
| L3 A | |
| L1 C | |
| L5 B | |
| L4 C | |
| L3 D | |
| L3 D | |
| L2 C | |
| L2 D | |
| L2 E | |
| L5 B | |
| L4 A | |
| L4 B | |
| L3 E | |
| L5 C | |
| L4 C | |
| L4 E | |
| L2 C | |
| L2 E | |
| -- -- -- | |
| L5 E | |
| L4 E | |
| L2 D | |
| L4 C | |
| L5 D | |
| L5 E | |
| L4 E | |
| L4 E | |
| L1 E | |
| -- -- -- | |
| -- -- -- | |
| L4 C | |
| L4 E | |
| L3 E | |
| -- -- -- | |
| Bayard PALocal | L4 E | 
| L5 E | |
| L5 E | |
| L4 E | |
| L3 E | |
| L4 E | |
| L5 E | |
| L4 E | |
| L1 D | |
| L3 D | |
| L5 C | |
| L4 D | |
| L4 E | |
| L3 E | |
| L1 B | |
| -- -- -- | |
| L3 E | |
| L5 E | |
| L3 E | |
| L1 E | |
| L2 C | |
| -- -- -- | |
| L2 C | |
| L3 B | |
| L2 B | |
| L1 D | |
| L2 D | |
| L2 E | |
| L1 B | |
| L1 D | |
| -- -- -- | |
| L2 D | |
| L3 E | |
| L2 D | |
| L2 E | |
| L1 D | |
| L1 D | |
| L2 E | |
| -- -- -- | 
No Attorneys